DKNG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
DraftKings Inc (DKNG) is not a strong buy for a beginner, long-term investor at this time. While the company has shown some positive developments, such as achieving GAAP profitability for the first time in Q4 2022 and expanding its market reach to Arkansas, the financial performance remains weak with declining net income, EPS, and gross margin. Additionally, the technical indicators suggest a bearish trend, and analysts have consistently lowered price targets, reflecting skepticism about growth and profitability. The options data shows a bullish sentiment, but it is not enough to offset the broader concerns. For a long-term investor, it may be better to wait for clearer signs of financial and operational improvement before investing.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting an overall downward trend. The stock is trading near its pivot level of 23.478, with resistance at 25.617 and support at 21.338.
DraftKings achieved GAAP profitability for the first time in Q4
Expansion into Arkansas, marking the 30th U.S. state where DraftKings operates.
Responsible gaming tools and enhanced user experience offerings.
Declining financial metrics, including net income (-12.56% YoY) and EPS (-13.33% YoY).
Analysts consistently lowering price targets, reflecting concerns about growth and profitability.
Bearish technical indicators and weak stock trend projections (-6.14% in the next month).
In 2025/Q3, revenue increased by 4.43% YoY to $1.14 billion. However, net income dropped by 12.56% YoY to -$256.8 million, and EPS declined by 13.33% YoY to -0.52. Gross margin also decreased to 31.46%, down 2.39% YoY.
Analysts have lowered price targets across the board, with recent targets ranging from $26.40 to $44. Most analysts maintain a Buy or Outperform rating, but the lowered targets reflect concerns about decelerating revenue growth, higher costs, and skepticism about prediction market investments.
